VYM241018P128000
- 1.35
- 0.000.00%
Vanguard High Dividend Yield ETF Newsroom
Stocks With the Highest Consensus of Expected ROE Growth, Goldman Sachs Says
Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
J&J, Legend Report Carvykti Cut Death Risk by 45% in Multiple Myeloma Study
J&J Releases Encouraging Data on Talvey Combination Therapies
Johnson & Johnson's CARVYKTI Is The First And Only Cell Therapy To Significantly Extend Overall Survival Versus Standard Therapies For Patients With Multiple Myeloma As Early As Second Line; 45% Reduction In Risk Of Death Achieved With CARVYKTI After...
Merck Snaps Six Straight Sessions of Losses
Home Depot's Options: A Look at What the Big Money Is Thinking
Walmart Analyst Ratings
Hurricane Helene Update: 28 Dead, Power Outages, Insurance Damages And More
Costco's Latest Quarter Shows Its Business Model Continues To Work Beautifully
Retail Pair Trade: Walmart Lands a Street-high PT From Citi, Dollar General Is Cut to Sell
Today's Pre-Market Movers and Top Ratings | COST, DG, BMBL, HPQ and More
Johnson & Johnson Announces Updated Results From The Investigational Phase 1b Trimm-2 Study Evaluating The Combination Of TALVEY And DARZALEX FASPRO Based Combination Shows Deep And Durable Responses In Patients With Relapsed Or Refractory Multiple...
J&J Snaps Six Straight Sessions of Losses
'Walmart Said It Plans To Install High-Tech Automaton From Artificial Intelligence-Based Supply Chain Technology Company Symbiotic In Two Of Its Regional Distribution Centers One In Buckeye, Ariz., And Another In Searcy, Ark.' - ChainStoreAge
Merck, Bristol-Myers Fail to Convince FDA AdCom on Wider Opdivo, Keytruda Use
Hurricane Helene Disrupts Flights, Sports Events, Disney Operations: Affected Regions, Stocks To Watch
Peering Into Coca-Cola Consolidated's Recent Short Interest
In-Depth Analysis: Johnson & Johnson Versus Competitors In Pharmaceuticals Industry
J&J to Shutter Cardiovascular, Metabolic Drug Unit: Report